Microvilli of the aggressive 13762 ascites mammary adenocarcinoma contain a large, microfilament-associated signal transduction particle whose scaffolding is a stable glycoprotein complex (Li, Y., Hua, F., Carraway, K. L., and Carraway, C. A. C. (1999) J. Biol. Chem. 274, 25651-25658) associated with the growth factor receptor p185neu . The receptor is constitutively tyrosine-phosphorylated in the cells and microvilli, predicting that it should recruit mitogenic pathway components to this membrane-microfilament interaction site. Immunoprecipitation of cell lysates with anti-phosphotyrosine and immunoblotting showed phosphorylated forms of the mitogenic pathway proteins Shc and MAPK in addition to p185 neu , suggesting that the Ras to MAPK mitogenic pathway is activated. Immunoblotting of p185 neu -containing microvillar fractions revealed the presence in each of stably associated Shc, Grb-2, Sos, Ras, Raf, mitogen-activated protein kinase kinase, and mitogenactivated protein kinase/extracellular signal-regulated kinase, as well as the transcription factor-phosphorylating kinase Rsk. All of these pathway components coimmunoprecipitated with p185neu from cleared lysates of microvilli solubilized under microfilament-depolymerizing conditions. The recruitment of constitutively phosphorylated p185 neu and the activated mitogenic pathway proteins to this membrane-microfilament interaction site provides a physical model for integrating the assembly of the mitogenic pathway with the transmission of growth factor signal to the cytoskeleton. This linkage is probably a requisite step in the global cytoskeleton remodeling accompanying mitogenesis.Growth factors trigger both mitogenesis and changes in cell morphology and microfilament organization (1). Since both of these effects result from the binding of the factors to a single type of receptor, their pathways must somehow be integrated. One suggestion for this integration is that the receptors and components of the signaling pathways are localized to sites where microfilaments interact with membranes (2). The EGF 1 receptor (3) and the EGF receptor family member p185 neu (ErbB2/HER2) (4) have been shown to be associated with microfilaments. EGF receptor binds directly to actin through a motif similar to the actin-binding motif of profilin (5). The mechanism for the association of p185 neu /ErbB2 with microfilaments is presently unclear. Interestingly, p185neu /ErbB2, which has been implicated in tumor cell metastasis, is proposed to play a role in the regulation of cell structure and motility (6). The receptor is concentrated on microvilli in SK-BR-3 breast cancer cells. Activation of its phosphorylation leads to cell spreading, enlargement of microvilli, formation of pseudopodia, and aggregation of the p185 at the plasma membrane protrusions and pseudopodia (6). A specific role for p185 neu /ErbB2 in these microfilament-dependent processes known to enhance metastatic capability of tumor cells was shown in p185 neuoverexpressing transfectants of NCI-H460 lung carcinoma ce...